Eric Rohren on Radium-223 Therapy for Bone Metastases - State of the Art Lecture

Eric M. Rohren, M.D. Ph.D., Professor and Chair, Radiology Baylor College of Medicine delivers a state of the art lecture on Radium-223 Therapy for Bone Metastases.  Dr. Rohren describes the basic types of radiation, the relative biological effectiveness, the background on radium-223 and the clinical rationale for use.  He goes into detail about the expereinces of radium-223 at MD Anderson.  He leaves us wih what we may know about radium-223 and some of what remains unanswered.  The lecture is followed by a discussion between Eric Rohren and Phillip Koo.  This presentation provides an indepth review of radium-223 from an expert based upon the clinical data and significant clinical expereinces.  

Reference: Etchebehere EC, Araujo JC, Fox PS, Swanston NM, Macapinlac HA, Rohren EM. Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival. J Nucl Med. 2015 Aug;56(8):1177-84. doi: 10.2967/jnumed.115.158626.   Read the Abstract 

Biosketch: Eric M. Rohren, MD Ph.D. 
Eric Rohren, MD. PhD., a national leader in radiology and nuclear medicine, has been chair of radiology at Baylor College of Medicine since October 1, 2015.   

Previously Dr. Rohren served as a professor in the Departments of Nuclear Medicine and Diagnostic Radiology, Division of Diagnostic Imaging, at the University of Texas MD Anderson Cancer Center and was chief of the Section of Positron Emission Tomography (PET).

Dr. Rohren has held leadership positions in several national groups, including the American College of Radiology, the Radiologic Society of North America, the American Board of Nuclear Medicine and the Society of Nuclear Medicine and Molecular Imaging. His research interests include cancer imaging, novel radiotracers in oncology and neurology and targeted radioisotope therapies. He has worked extensively on PET/CT reporting and has developed guidelines for report structure and content through his work with the PET Utilization Task Force.

Dr. Rohren received his bachelor’s degree from St. Olaf College in Northfield, Minn., and earned his medical degree from Mayo Medical School in Rochester, Minn., and his doctorate from Mayo Graduate School in Immunology. He completed residency in diagnostic radiology and fellowship training in nuclear medicine at Duke University Medical Center in Durham, N.C., and is board certified by the American Board of Radiology and the American Board of Nuclear Medicine.

Dr. Rohren was on the MD Anderson faculty from 2007 until his appointment at Baylor College in 2015 and prior to that held appointments as a faculty physician at the Mayo Clinic and as medical director of several molecular imaging centers in Florida.